Intervention Review

Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)

  1. Maite Vallejo*,
  2. Pedro PA Reyes

Editorial Group: Cochrane Heart Group

Published Online: 18 OCT 2005

Assessed as up-to-date: 12 SEP 2010

DOI: 10.1002/14651858.CD004102.pub2

How to Cite

Vallejo M, Reyes PPA. Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection). Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD004102. DOI: 10.1002/14651858.CD004102.pub2.

Author Information

  1. Juan Badiano No. 1. Col. Seccion XVI, Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, Mexico

*Maite Vallejo, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano No. 1. Col. Seccion XVI, Tlalpan, C.P. 14080, Mexico. maite_vallejo@yahoo.com.mx.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 18 OCT 2005

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Margaret O Lau-Walker, Martin R Cowie, Michael Roughton, Coronary heart disease patients’ perception of their symptoms and sense of control are associated with their quality of life three years following hospital discharge, Journal of Clinical Nursing, 2009, 18, 1
  2. 2
    James H. Diaz, Reply, Journal of Travel Medicine, 2008, 15, 5